A B S T R A C T Under certain conditions, exogenously administered cholecystokinin (CCK) or its COOH-terminal octapeptide can terminate feeding and cause behavioral satiety in animals. Furthermore, high concentrations of CCK are normally found in the brains of vertebrate species. It has thus been hypothesized that brain CCK plays a role in the control of appetite. To explore this possibility, a COOH-terminal radioimmunoassay was used to measure concentrations ofCCK in the cerebral cortex, hypothalamus, and brain stem of rats and mice after a variety of nutritional manipulations. CCK, mainly in the form of its COOH-terminal octapeptide, was found to appear in rat brain shortly before birth and to increase rapidly in cortex and brain stem throughout the first 5 wk of life. Severe early undernutrition had no effect on the normal pattern of CCK development in rat brain. Adult rats deprived of food for up to 72 h and rats made hyperphagic with highly palatable diets showed no alterations in brain CCK concentrations or distribution of molecular forms of CCK as determined by Sephadex gel filtration of brain extracts. Normal CCK concentrations were also found in the brains of four strains of genetically obese rodents and in the brains of six animals made hyperphagic and obese by surgical or chemical lesioning of the ventromedial hypothalamus. It is concluded that despite extreme variations in the nutritional status of rats and mice, CCK concentrations in major structures ofthe brain are maintained with remarkable constancy.
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INTRODUCTION
Over the past few years, reports from several laboratories have suggested a new role for the gastrointestinal hormone cholecystokinin (CCK),1 in addition to its known function as a stimulator of the gall bladder and Received for publication 24 April 1979 and in revised form 28 June 1979. 1 Abbreviations used in this paper: CCK, cholecystokinin; CCK-8, COOH-terminal octapeptide of CCK; CCK-33, triacontatriapeptide cholecystokinin; VMH, ventromedial hypothalamus. 1348 exocrine pancreas. That this hormone may serve as a satiety signal was suggested by a series of experiments which showed that injections of either CCK-33 or CCK-8 could induce not only cessation ofeating but the full sequence of "behavioral satiety" in rats (1) (2) (3) (4) . In addition, it has been shown that CCK injected directly into the cerebral ventricular system can diminish frequency of bar pressing for a meal in rats (5) . These observations, combined with the intriguing findings of large concentrations of CCK within the central nervous system (6) (7) (8) (9) and a recent demonstration of greatly diminished concentrations of CCK in the brains of a strain of genetically obese rodent (10) have increased interest in the potential function of CCK as a satiety signal within the central nervous system and in the periphery.
If brain CCK is somehow involved in the neuroregulation of appetite, it is likely that alterations in nutrition and feeding behavior might be associated with changes in the levels or anatomic distribution of this peptide within the central nervous system. Significant alterations in the feeding behavior and body composition ofrodents are known to result from dietary manipulations, brain lesioning, and genetic mutations. In this study, an analysis of the concentration of brain CCK-like immunoreactivity of rats and mice in these conditions is presented to determine whether associated perturbations in concentration, molecular form, or regional anatomic distribution of brain CCK can be demonstrated.
METHODS
Development of radioimmunoassay. The antiserum employed in this study was produced, in a rabbit, to the desulfated COOH-terminal octapeptide ofCCK (kindly supplied by tracer in the assay. Iodination was achieved using minor modifications of the chloramine-T method (11) . To 20 ,ul of 0.5 M PG4 buffer, pH 7.5, were added in rapid sequence, 1.0 mCi 125I, 500 ng CCK-8, and 25 ,ug chloramine-T. The total reaction volume was 35 ,ul. Less than 10 s after addition of chloramine-T, the reaction was terminated by adding 50 jig sodium metabisulfite to the mixture. Separation ofthe 125I-CCK-8 from damaged components and from unreacted 125J-was effected by passing the remainder of the reaction mixture over a Bio-Gel P-2 column (Bio-Rad Laboratories, Richmond, Calif.).
The radioimmunoassay was performed in 0.02 M Veronal buffer pH 8.6 with 0.2% bovine serum albumin. Synthetic (sulfated) CCK-8 was used as standard. After a 2-d incubation at 4°C, 1 cm3 of cold assay buffer containing 0.1 cm3 human plasma was added to each tube. Immediately thereafter, bound and free 125I-CCK-8 were separated by the addition of 20 mg charcoal (Norit A suspension) to each tube, followed by centrifugation at 4°C for 15 min to separate the unreacted 125I-CCK-8 from antibody-bound radioactivity, damaged components, and free 125I-.
Brain extraction. All animals were fed standard Purina laboratory rat chow (Ralston Purina Co., St. Louis, Mo.) unless otherwise specified. The animals were maintained on alternating 12-h light-dark cycles and were sacrificed in the afternoon by rapid decapitation. The brains were immediately dissected and each anatomic area to be analyzed was weighed and then boiled in a 10-fold volume of distilled water for 3 min. During boiling, the tissues were ground with glass rods. The time taken from decapitation to boiling the tissue was minimized (<4 min) in an attempt to limit proteolysis. Brain extracts were stored frozen at -20°C until assayed. Assays were carried out at multiple dilutions of each sample to optimize precision and ensure that the unknowns and CCK-8 standard exhibited parallel binding inhibition curves.
Gel filtration patterns. Brain extracts from a number of animals under each experimental condition were further analyzed by Sephadex gel filtration using Sephadex G-50 fine columns (column dimensions were 1.5 x 60 cm). 500-,ul samples were applied to the columns and eluted with buffer identical to that used in the assay. 1.0-cm3 fractions were collected. The flow rate was 10 cm3/h, and all gel filtration procedures were done at 4°C. Marker molecules (blue dextran 2000, porcine CCK-33 [V. Mutt, Karolinska Institute, Stockholm, Sweden], CCK-8, 125I-) were used to identify the peaks of immunoreactivity. To rule out noncovalent aggregation as a source ofhigher molecular weight immunoreactivity, the integrity of immunoreactive peaks eluting earlier than CCK-33 was tested by incubating G-50 void volume material in 8 M urea and rerunning it on Sephadex columns in the presence of 4 M urea.
Dietary manipulations. Experiments were carried out to test the effects of over-and undernutrition on the concentration ofbrain CCK in rats. After each experiment, animals were sacrificed and their brains dissected and extracted as described above.
To study the effect ofundernutrition on the concentration of brain CCK, groups of adult, male Sprague-Dawley rats were fasted for 72 h. Control rats had ad lib. access to standard laboratory chow. Both the control and food-deprived groups were housed in individual hanging cages and were given ad lib. access to water. Animals were weighed before sacrifice to verify food deprivation and weight loss. After the 72-h fast, the rats had lost 10-15% of their body weights. Brain weights in the fasted group were identical to those of controls.
The effect of chronic undernutrition in early life was examined by placing newborn rats in artificially enlarged litters of 22 pups each. Animals reared in this manner suffer significant early malnutrition and remain stunted as adults (12) (13) (14) .
At ages 2, 3, and 4.5 wk, large-litter animals were sacrificed and their brains extracted as described above. Control rats reared in normal size litters of 10 pups each were also sacrificed at ages 2, 3, and 4.5 wk. In addition, rats from normal sized litters were sacrificed at various times in early life to determine when CCK reaches its maximum concentration in the developing rat brain.
To determine the effects of chronic overfeeding on brain CCK, Osborne Mendel rats were fed a diet consisting of 55% fat for 5 mo. This diet is highly palatable to these rats, as was evidenced by hyperphagia and marked weight gain relative to chow-fed controls. At the end of the 5-mo period the obese, high fat-fed animals weighed 808+20 g, compared with a mean weight of 592±15 in the control group (P < 0.01).
Similar diet-induced hyperphagia and obesity can be achieved by supplementing the standard chow diet with sucrose solutions (15) . Osborne Mendel rats were made obese by feeding them a chow diet with ad lib. access to a 16% sucrose solution for 7 mo. At the end of this period, the sucrosefed animals were markedly obese, weighing 924±51 g.
An additional group of Sprague-Dawley rats made hyperphagic by feeding the sucrose-supplemented diet for 2 wk was also studied.
Finally, a group of chow-fed Sprague-Dawley rats was sacrificed during the dark phase of their day-night cycle to determine whether their marked predilection for nocturnal eating is associated with changes in brain CCK levels.
Genetically obese rodents. Four strains of genetically obese, hyperphagic rodents were studied. Obese animals and their lean littermates were sacrificed and their brains dissected and extracted as described above. In each group, the obese and lean animals were sacrificed on the same day, in the fed state, and during the light phase of their 12-h lightdark cycles.
Groups of young (age 5 wk) and adult (age 1 yr) Zucker fatty rats (fafa), together with their lean littermates (Fa/?) were studied (kindly donated by Dr. P. R. Johnson and Dr. R. Hemmes, Department of Biology, Vassar College, Poughkeepsie, N. Y.). Adult obese animals had a mean brain weight of 1.88±0.003 g, whereas their lean littermates had a mean brain weight of 1.93±0.01 g (P < 0.01). In the younger group, the obesity had been evident on gross inspection for 2 wk; although the obese and lean animals do not usually differ significantly in total body weight at this time in life, there are marked differences in body composition, the fatties having a smaller lean body mass and a greater amount of total body fat than their lean littermates (16) . These differences in body composition are easily recognizable in the intact 5-wk-old animals; the fatties appear shorter and rounder than their lean littermates. The 5-wk-old fatties had a mean brain weight of 1.45±0.02 g, whereas the lean littermates had a mean brain weight of 1.66±0.03 g (P < 0.01).
Five groups of ob/ob mice (all mice used in this study were obtained from Jackson Laboratories, Bar Harbor, Maine), together with their lean (C 57/BL 6J +/?) littermates were studied. The groups ranged in age from 5 wk to 9 mo. With the exception of the 5-wk-old group, the ob/ob animals were much heavier than their lean littermates (Table III) . In each group for which total brain weight data is available, the brains of ob/ob mice weighed significantly less (P < 0.01) than their lean littermates; at age 11 wk, 380.9±6.4 mg for the obese, 430.3 ±4.3 mg for the lean; at age 15 wk, 391.2 ±4.2 mg for the obese, 433.7±3.0mg for the lean; at 6 mo, 378.8±2.0mg for the obese, 422.1±3.0 mg for the lean; at age 9 mo, 389.0±10.0 mg for the obese, 437.2± 10.2 mg for the lean. Additionally, portions of brains of ob/ob mice and their lean littermates at ages 15 wk and 6 mo were boiled in 0.1 N HCl for 3 min as described previously (8, 10) to determine whether the mode of extraction had any effect on our ability to detect differences between the obese and lean animals.
Two separate groups of obese yellow mice (C57BL/6J AY/a), together with their normal weight C57BL/6J a/a littermates were analyzed for brain CCK content. Animals were studied at ages 4 and 8 wk. There was no difference in body weights between yellow and black littermates at age 4 wk. However, at 8 wk, the yellow mice had a significantly greater body weight than their lean littermates (P < 0.01). These data are essentially identical with an earlier report on the development of obese yellow mice (17) . There were no differences in brain weights between yellow mice and lean controls at either age. An additional group of three yellow mice, aged 20 wk, was studied although lean littermates were not available for this group.
Finally, six obese C57BL/6J db/db mice and their lean littermates C57BL/6J +/? were studied at age 15 wk.
Brain-lesioned animals. Chemical or physical lesions to the ventromedial hypothalamus (VMH) result in hyperphagia and obesity (18, 19 29 .6±9 g (P < 0.01). The brains of the gold-thioglucose-injected group weighed slightly less than those of the sham-injected controls: 414±4 mg for the gold-thioglucose animals and 430±7 mg for the controls. At this time they were sacrificed and their brain CCK concentrations were determined.
RESULTS
Radioimmunoassay. When the products of the CCK-8 radioiodination reaction were filtered through a Bio-Gel P-2 column, the elution pattern of radioactivity appeared as shown in Fig. 1 . The specific activity of the '251-CCK-8 produced in this reaction, calculated from measuring the radioactivity in column eluates, is -800 ,uCi/,g. Generally, 95% of the radioactivity present in the radiolabeled octapeptide in peak II was capable of binding to charcoal. After a 2-d incubation under radioimmunoassay conditions, 92-94% of the radioactivity present in control tubes (incubated under identical conditions but without antibody), remained charcoal-bindable.
Characteristics of the antiserum employed in this study are shown in Fig. 2 (Fig. 2) . The intraassay coefficient of variation was 9% at 25 pg/ml (n = 10). The interassay coefficient of variation was 13% at 25 pg/ml (n = 8). When aqueous brain extracts were stored at -20°C the interassay coefficient ofvariation was generally < 15% over a 6-mo period. However, acid extracts (0.1 N HCI) of brain failed to retain full immunoreactivity on storage in the frozen state, with losses of up to 50% after 2 mo at -20°C. Greater stability of acid extracts could be achieved by diluting the extracts in assay standard buffer before freezing.
When exogenous CCK-8 was added to brain tissue just before extraction the recovery of immunoreactive CCK-8 after boiling of the tissue in water for 3 min was essentially 100%.
Regional distribution of CCK immunoreactivity in rat brain. CCK shown in Table I . These data are essentially in agreement with other published reports on the anatomic distribution ofCCK in human and porcine brain (6, 20) .
Sephadex G-50 gelfiltration patterns. Fig. 3 (Fig. 3) . Very little CCK is present in extracts of brains taken from rats at the time of birth. The CCK immunoreactivity appears in the brain stem and cortex at approximately the same time in early development and rapidly increases throughout the brain during the 1st mo of life (Fig. 5A) . When the data is expressed as percent Braini Cholecystokinin adult level, the rates of increase of CCK concentration in the brain stem and cortex are the same (Fig. 5B) . Sephadex gel filtration patterns of extracts taken from various parts of the brain in early life were all identical to the adult pattern.
While the levels of CCK in the brains of rats close to the time of birth were extremely low, boiled water extracts of duodenum in these same animals contained levels of immunoreactivity comparable to those found in adult animals. 3 Rats undernourished from birth showed no differences in brain CCK concentrations at 2, 3, and 4.5 wk of age, from those found in rats reared in normal sized litters (Table III) .
No differences in the whole brain concentrations of CCK were seen in animals made obese by diets high in fat or supplemented with sucrose (Table II) . Sephadex gel filtration patterns of brain extracts from these obese animals showed no differences in the molecular distribution of CCK immunoreactivity from that found in chow-fed controls.
The brains of animals sacrificed during the dark phase of their day-night cycle had concentrations of CCK immunoreactivity which were identical to those found in animals sacrificed during the light phase (Table II) .
Genetically obese rodents. As shown in Table II , the concentrations of CCK in the brains of Zucker fatty rats did not differ from those found in their lean littermates. Sephadex gel filtration patterns of immunoreactive CCK in the boiled water extracts of obese Zucker rat brains and in extracts of lean Zucker rat brains were identical with the usual patterns found in Sprague-Dawley rats (Fig. 6) .
Similar results were obtained from the three strains of genetically obese mice: the CCK concentrations found in the brains of the obese animals did not differ from those found in the brains of their lean littermate controls (Table IV) . Boiled 0.1 N HCl extracts of mouse brains generally contained somewhat less immunoreactive CCK than boiled water extracts. However, the CCK content of boiled acid extracts of ob/ob mouse brains did not differ from that of their lean littermates (Table IV) .
Brain-lesioned aninmals. As shown in Tables II and III no differences were detected in the conicentrations of brain CCK in major dissected brain regionis of rats or mice made hyperphagic and obese by chemical or surgical lesions to the VMIH.
DISCUSSION
If the large quantities of CCK that reside within the brain function as a link in the chaini of neurochemical events leading to the perception of hunger or satiety, one might expect to detect changes in brain CCK levels in association with short-term or chronic alterations in nutritional status and feeding behavior.
Our data demonstrate that extremes in nutritional status and feeding behavior have no apparent effect on the concentration of immunoreactive CCK in major anatomic regions ofthe brains of rats and mice. Animals made hungry by 72 h of total food deprivation showed no differences in the levels, molecular forms, or regional distribution of brain CCK from those found in control animals. Unaltered concentrations and rates of appearance of brain CCK were also found in stunted animals which had been chronically undernourished from birth by placing them in artificially enlarged litters. In addition, analysis of genetic, diet-induced, and brainlesioned models of hyperphagia and obesity showed no associated alterations in brain CCK concentrations.
Our data showing that ob/ob mice have normal concentrations of brain CCK are in contrast to a recent report describing greatly diminished levels of CCK immunoreactivity in the cerebral cortex of this obese strain (10) . In studying these animals, both laboratories employed COOH-terminal assay systems which presumably have the same specificity. The concentration, regional anatomic distribution, and molecular heterogeneity of immunoreactive CCK which we have observed in the brains of rodents are similar to results published in several studies of brain CCK in other mammalian species. In addition, a major fraction of the CCK immunoreactivity present in brain homogenates is detectable in a synaptosomal fraction using our assay system, in agreement with the published report of Pinget et al. (22) . Straus and Yalow used 0.1 N HCI in their extraction procedure, whereas we used boiling distilled water for our nutritional experiments. However, when we assayed boiled 0.1 N HCI extracts of the brains of two groups of adult ob/ob mice, we again found no differences between obese animals and their lean littermates. Both laboratories obtained the ob/ob mice from Jackson Laboratories. Straus and Yalow report no differences in brain weights between ob/ob mice and their lean littermates. In contrast, we find that at every age studied, the ob/ob mice had significantly lower brain weights than their lean littermates, 4Goldman, S., and B. Schneider. Unpublished data. several observations in rats undernourished from birth have shown preferential loss of glia and myelin, whereas neuronal cell number did not diminish. Neuronal cell size and morphology may also be altered in these animals (13) (14) (15) 27) . A recent report on ob/ob mouse brains demonstrated brain weight, cerebroside content, and DNA content to be 90, 48, and 74%, respectively, of that found in the lean littermates (24) . Therefore, until more is learned about the physiology of brain CCK, the mode of expression of levels of immunoreactivity (whole brain content, content per gram wet weight of brain, content per microgram of DNA, etc.) must be approached with some caution. In summary, our data show that extreme alterations in nutritional status, accompanied in a variety of ways, do not change cerebral cortical, hypothalamic, or brain stem concentrations of CCK in rats and mice. The only significant changes we have thus far observed in brain CCK concentrations accompany the early postnatal development of the rat, and these increases occur during a period of rapid brain growth and closely parallel those reported for many brain constituents, including the neurotransmitters dopamine and norepinephrine (28, 29) . Certainly, our study does not rule out the possibility that CCK may serve as a neuroregulator of appetite in some part of the brain, most likely the hypothalamus. More refined anatomic and neurophysiologic studies are required to prove such a function. Until these are available, the role of central nervous system CCK-like peptides remains uncertain.
